Trending Clinical Topics for August 2018

Ryan Syrek

Disclosures

August 31, 2018

Trending Clinical Topic of the Week (August 18-24): Sleep

A study revealing a potentially concerning association and a new drug approval helped push a basic component of daily health to become this week's top search term. Although the Centers for Disease Control and Prevention (CDC) recommends that adults aged 18-60 years get 7 or more hours of sleep per night, a new study found that more sleep isn't necessarily better. New research suggests that people who sleep longer than 8 hours each night may be at higher risk for premature death and development of cardiovascular disease. The study found that sleeping for 9 hours increased the risk of dying from any cause by 14%, sleeping 10 hours increased the risk by 30%, and sleeping for 11 hours increased the risk by 47%. The researchers also found that poor sleep quality was associated with a 44% increased risk for coronary heart disease.

Meanwhile, the US Food and Drug Administration (FDA) approved Jornay PM, a methylphenidate formulation intended to help control symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. The drug is administered prior to sleep, between 6:30 PM and 9:30 PM, to provide early-morning control of ADHD symptoms in children aged 6 years and older. The drug has two functional film coatings; the first delays the initial release of the drug for as long as 10 hours, and the second controls the rate of the active ingredient's release throughout the day. Although sleep is often on the mind for most healthcare professionals, concern about too much of it and a novel drug helped make the term this week's top trending topic.

For more information on normal sleep and sleep physiology, read here

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....